Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine

Beatriz Quiambaoa Clinical Research Division, Research Institute for Tropical Medicine, Alabang, Muntinlupa City, PhilippinesView further author information

Paula Peyranib Pfizer Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, PA, USACorrespondence[email protected]
View further author information

Ping Lib Pfizer Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, PA, USAView further author information

Mark W. Cutlerc Pfizer Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USAView further author information

John L. Perezb Pfizer Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, PA, USAView further author information

Chris Webbere Pfizer Vaccine Clinical Research and Development, Pfizer Inc, Hurley, UKView further author information

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.